Our goal is for you or your loved one to get the most out of your doctor's visit and recognize the symptoms
that may lead to uncontrolled asthma. Whether you're just beginning your treatment journey or looking for
another way to treat your moderate-to-severe asthma, take a moment to answer a few questions. Then use
this guide to help start that conversation with your doctor to see if DUPIXENT may be right for you.

  • Personal Info
  • Journey
  • Symptom Severity
  • Asthma Control
  • Review


We've gathered your answers in a personalized guide that you can save by choosing an option below.
You can save the results of this page for easy referral by adding it to your bookmarks.

Please remember that this is intended to be a helpful way for you to prepare for your conversation
with your provider, but should not replace a full conversation with your provider.



Let's set an appointment on your calendar to remind you of your next doctor's visit. It will include a link to your personalized discussion guide for easy reference, which will help you lead a productive conversation with your doctor.

I am a:


Time since diagnosis:



Coughing:  Moderate

Wheezing:  Frequently

Shortness of breath:  Frequently

Rapid breathing:  Moderate

Chest tightness:  Occasionally


Awoken at night:

(Because of symptoms
in the past month)

Been to emergency room:

(In the past year)

Limited or missed an activity:

(Because of an attack)

Used rescue inhaler:

(More than twice a week)






DUPIXENT is a prescription medicine used with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age or older whose asthma is not controlled with their current asthma medicines. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT may also help reduce the amount of oral corticosteroids you need while preventing severe asthma attacks and improving your breathing. DUPIXENT is not used to treat sudden breathing problems. It is not known if DUPIXENT is safe and effective in children with asthma under 6 years of age.

Important Safety Information

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.

Please see additional Important Safety Information for DUPIXENT on next page.


  • How does DUPIXENT work differently
    from other treatment options?
  • How does DUPIXENT work?
  • How would I take DUPIXENT?
  • How do I get started with DUPIXENT?
  • What are the possible side effects of DUPIXENT?
  • How can DUPIXENT help treat my uncontrolled
    moderate-to-severe asthma?


Add any additional notes to discuss with your doctor.

Important Safety Information and Indication

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:

  • have a parasitic (helminth) infection
  • are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during treatment with DUPIXENT.
  • are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or use an asthma medicine. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.

DUPIXENT can cause serious side effects, including:

  • Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.
  • Inflammation of your blood vessels. Rarely, this can happen in people with asthma who receive DUPIXENT. This may happen in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. It is not known whether this is caused by DUPIXENT. Tell your healthcare provider right away if you have: rash, chest pain, worsening shortness of breath, a feeling of pins and needles or numbness of your arms or legs, or persistent fever.
  • Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.

The most common side effects in patients with asthma include injection site reactions, pain in the throat (oropharyngeal pain), high count of a certain white blood cell (eosinophilia), and parasitic (helminth) infections.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.

Use DUPIXENT exactly as prescribed by your healthcare provider. It’s an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider. In children 12 years of age and older, it’s recommended DUPIXENT be administered by or under supervision of an adult. In children under 12 years of age, DUPIXENT should be given by a caregiver.

Please see accompanying full Prescribing Information including Patient Information.

© 2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUPIXENT® and DUPIXENT MyWay® are registered trademarks of Sanofi Biotechnology.
DUP.21.11.0184   Last Update: January 2022